CSS
CME icon

Cubist Systematic Strategies’s CME Group CME Stock Holding History

Cubist Systematic Strategies’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$14.4M Buy
53,400
+2,800
+6% +$762K 0.07% 401
2025
Q2 		$13.9M Buy
50,600
+42,900
+557% +$11.7M 0.06% 436
2025
Q1 		$2.04M Sell
7,700
-2,700
-26% -$666K 0.01% 1406
2024
Q4 		$2.42M Buy
10,400
+7,900
+316% +$1.82M 0.02% 1241
2024
Q3 		$552K Sell
2,500
-2,700
-52% -$559K ﹤0.01% 2163
2024
Q2 		$1.02M Buy
5,200
+2,200
+73% +$455K 0.01% 1729
2024
Q1 		$646K Sell
3,000
-11,700
-80% -$2.46M ﹤0.01% 2462
2023
Q4 		$3.1M Buy
14,700
+3,000
+26% +$640K 0.02% 1179
2023
Q3 		$2.34M Buy
11,700
+500
+4% +$99.4K 0.02% 1256
2023
Q2 		$2.08M Sell
11,200
-4,500
-29% -$832K 0.01% 1462
2023
Q1 		$3.01M Sell
15,700
-55,400
-78% -$10M 0.02% 1339
2022
Q4 		$12M Buy
71,100
+31,900
+81% +$5.54M 0.07% 385
2022
Q3 		$6.94M Buy
39,200
+24,800
+172% +$4.9M 0.04% 770
2022
Q2 		$2.95M Buy
+14,400
New +$3.05M 0.02% 1481

Other funds holding CME

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Cubist Systematic Strategies's CME Position: Q3 2025 in Review

Cubist Systematic Strategies reduced its CME Group (CME) stake by 33% in Q3 2025, selling an estimated $10M and leaving 75,000 shares worth $20.3M. The position accounts for 0.1% of the portfolio, ranked #276.

Cubist Systematic Strategies first reported a position in CME in Q2 2014 and has held it in 45 quarters since. The position peaked at $60.2M in Q2 2024. 1,650 funds tracked by Wall St. Rank hold CME as of Q3 2025.

  • Cubist Systematic Strategies held 75,000 shares of CME Group worth $20.3M as of Q3 2025.
  • Cubist Systematic Strategies sold 36,817 CME Group shares in Q3 2025, an estimated $10M.
  • CME Group made up 0.1% of Cubist Systematic Strategies's portfolio in Q3 2025, its #276 holding.
  • Cubist Systematic Strategies first reported a position in CME Group in Q2 2014 and has held it in 45 quarters since.
  • Cubist Systematic Strategies's CME Group position peaked at $60.2M in Q2 2024.
  • 1,650 funds tracked by Wall St. Rank held CME Group as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.